Mepha Pharma AG - Oxycodon-Naloxon-Mepha 30 mg/15 mg, Retardtabletten | | 65742 | | 05 | | Oxycodon-Naloxon-Mepha 30 mg/15 mg | | Retardtabletten | | N02AA55 | | Oxycodone and Naloxone | | 28.01.2019 | | |
| Composition | oxycodoni hydrochloridum 30 mg, naloxoni hydrochloridum anhydricum 15 mg ut naloxoni hydrochloridum dihydricum, poly(vinylis acetas), povidonum K 30, natrii laurilsulfas corresp. natrium 0.05 mg, cellulosum microcristallinum, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), talcum, E 171, macrogolum 3350, E 172 (flavum), pro compresso obducto. | Packungsbestandteile | | Delayed release tablets | | Active Agent | Dose |
---|
Naloxone Hydrochloride Anhydrate | 15 mg | Oxycodone Hydrochloride | 30 mg |
| | Inactive agents | Dose | additional_information |
---|
| | | | | | | | color. | | | color. | Macrogol | 3350 | | | | | | | | | | Überzug | | | | | 30 | | | | | Silica Colloidalis Anhydrica | | | Talcum | | |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
---|
009 | 30 | PR | PR | A+ | | Yes | 010 | 60 | PR | PR | A+ | | Yes |
|
|